A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach (REVISE)

March 18, 2026 updated by: Adrián Montesano, Universitat Oberta de Catalunya

A Virtual Reality Couples' Intervention for Sexual Victimization Prevention: a Gender-swapping Transformative Approach (REVISE)

The goal of this clinical trial is to evaluate the effectiveness of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention designed to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men.

The main questions that this study aims to answer are as follows.

Does experiencing gender swapping in IVR increase empathy towards survivors of sexual harassment?

Does the intervention modify attitudes toward gender roles and sexual harassment?

Researchers will compare the three experimental groups to evaluate the effects of IVR:

  1. Identity Exchange Group with Exposure to Sexual Harassment: Participants embodied their partner's identity in a VR harassment scenario.
  2. Identity Exchange Group without Harassment Exposure: Participants embodied their partner's identity in a neutral VR scenario.
  3. Third-person Observer Group: Participants observe a harassment scenario in VR from their own perspective.

Participants will:

  1. Attend one virtual reality session in a laboratory setting.
  2. Undergo pre- and post-intervention assessments and a three-month follow-up.
  3. Complete self-report questionnaires and physiological measures (eye tracking and pupillometry).
  4. Participate in semi-structured interviews about their experiences. This study aims to explore how immersive VR embodiment can be used as a tool for gender violence prevention by fostering perspective-taking and behavioral change.

Study Overview

Detailed Description

This study is a randomized controlled trial (RCT) designed to evaluate the efficacy of REVISE (REalidad Virtual Inmersiva y SExualidad), an immersive virtual reality (IVR) intervention, to promote empathy and reduce sexual harassment behaviors in heterosexual cisgender men. This study will assess whether experiencing sexual harassment from a first-person perspective using IVR embodiment techniques can lead to changes in attitudes and behaviors related to gender roles and sexual violence.

Study Design

  • Design: Randomized controlled trial (RCT) with a 1:1:1 allocation ratio.
  • Population: 90 heterosexual cisgender couples (180 participants) aged 18-39 years.
  • Study Setting: This study will be conducted in a controlled laboratory environment at the Interdisciplinary Research and Innovation Hub of the Universitat Oberta de Catalunya (UOC), equipped with advanced VR and physiological tracking technologies.
  • Conditions:

    1. Identity Exchange with Exposure to Sexual Harassment (Experimental Condition 1)
    2. Identity Exchange without Harassment Exposure (Experimental Condition 2) 3. Third-person Observer Condition (Control Group)
  • Intervention Duration: One VR session (~60 minutes) with pre- and post-intervention assessments and a three-month follow-up.

Intervention Procedures

  1. Pre-intervention assessment

    • Participants complete self-report questionnaires measuring empathy, gender role attitudes, and harassment perceptions.
    • Baseline physiological measures (eye tracking and pupillometry) are recorded. - Participants are assigned to one of the three conditions.
  2. VR Intervention:

    • Participants undergo a mirror embodiment task to establish a sense of virtual body ownership.
    • The male participant embodies his female partner's avatar in a VR scenario (conditions 1 and 2).
    • Participants experience the designated VR scenario (harassment, neutral, or observational).
    • Physiological responses are collected in real time.
  3. Post-intervention assessment

    • Participants complete self-report measures to assess changes in empathy and gender attitudes.
    • Physiological data analysis (pupil dilation and eye gaze fixation) is conducted. - Semi-structured interviews explore subjective experiences.
  4. Three-month follow-up:

    • Participants complete longitudinal measures to assess sustained behavioral and attitudinal changes.

Outcome Measures

1. Primary Outcome: Change in empathy scores (Interpersonal Reactivity Index). 2. Secondary Outcomes:

  • Gender role attitudes (Ambivalent Sexism Inventory).
  • Dyadic relationship quality and flourishing
  • Harassment-related attitudes - Eye-tracking and pupillometry responses during VR.
  • Qualitative insights from the post-intervention interviews.

Sample Size Justification A sample of 90 couples (180 individuals) was determined based on an estimated effect size of d = 0.5, an alpha risk of 0.05, and a power of 0.86. Participants will be randomized using block randomization (block sizes of 3 or 6) to ensure balance across the conditions.

Data Management and Quality Assurance

  1. Data Collection

    • Self-reported data will be collected using secure online survey tools.
    • Physiological data will be automatically recorded using VR-compatible eye-tracking and pupillometry systems.
  2. Data Validation and Security

    • The dataset will undergo automatic range checks to detect anomalies.
    • Double data entry procedures will be implemented for self-report responses.
    • Only authorized researchers will have access to identifiable data, stored on encrypted servers.
  3. Missing Data Handling:

    • Missing values will be addressed using multiple imputation techniques.
    • Sensitivity analyses will be conducted to determine the impact of the missing data.

Statistical Analysis Plan

  1. Primary Analysis:

    - Repeated measures ANOVA will assess within- and between-group differences in empathy scores over time.

  2. Secondary Analyses:

    • Generalized Estimating Equations (GEE) will model longitudinal changes in gender attitudes.
    • Mixed-effects models will analyze physiological responses (eye tracking and pupil dilation).
    • Qualitative data from the interviews will be subjected to thematic analysis using NVivo software.

Ethical Considerations

  • The study has received approval from the Research Ethics Committee of the Universitat Oberta de Catalunya.
  • Participants will provide informed consent prior to participation.
  • Psychological debriefing and support resources will be available to participants.

Dissemination Plan

The findings will be as follows:

  • Peer-reviewed journal publications.
  • Academic conferences in psychology, gender studies, and VR research.
  • Open science repositories for data transparency.

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Pablo Vallejo Medina, Doctor
  • Phone Number: +34613028333
  • Email: pvallejom@uoc.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants must be between 18 and 39 years old.
  • Couples must have been in a romantic relationship for at least six months.
  • Both partners must provide explicit informed consent to participate.
  • Participants must be able to read and write in Spanish to ensure comprehension of the study materials.

Exclusion Criteria:

  • Individuals with any physical condition that may hinder the use of VR equipment (e.g., epilepsy or severe motion sickness).
  • Individuals with a history of sexual harassment or problematic substance use, including drug or alcohol abuse.
  • Individuals experiencing significant mental health difficulties that require intensive treatment.
  • Participants with prior exposure to similar VR-based gender perspective-taking interventions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Identity Exchange with Exposure to Sexual Harassment
Participants will experience a virtual reality (VR) perspective-taking intervention in which they embody their female partner's avatar in a scenario depicting sexual harassment. This immersive experience aims to enhance empathy and reduce the acceptance of sexual harassment. Physiological responses (eye tracking and pupillometry) will be recorded, and participants will complete pre- and post-intervention self-reports.
Participants will embody a virtual avatar of their female partner in a sexual harassment scenario using full-body tracking, and identity exchange in virtual reality (VR). The goal is to assess whether experiencing harassment from a first-person perspective increases empathy and decreases tolerance toward sexual harassment.
Experimental: Identity Exchange without Harassment Exposure
Participants will embody their female partner's avatar in a neutral VR scenario without any harassment. This condition serves to evaluate the effects of identity exchange alone, without exposure to gender-based violence, on empathy and gender attitudes. Pre- and post-intervention assessments and physiological measures will be collected.
Participants will embody a virtual avatar of their female partner in a neutral social interaction scenario using VR-based identity exchange. This condition controls for the effect of perspective-taking alone, without exposure to harassment, to evaluate its impact on empathy and gender attitudes.
No Intervention: Third-Person Observer Condition
Participants will observe a VR scenario depicting sexual harassment from a third-person perspective, without experiencing identity exchange. This condition acts as a control to determine whether passive observation differs from immersive perspective-taking in modifying attitudes toward gender-based violence. Self-reports and physiological responses will be also analyzed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Empathy Scores (Interpersonal Reactivity Index - IRI)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
Empathy will be assessed using the Interpersonal Reactivity Index (IRI), a validated self-report measure that evaluates different components of empathy, including perspective-taking and empathic concern. The IRI consists of 28 items, each rated on a 5-point Likert scale (0 = Does not describe me well to 4 = Describes me very well). The total score ranged from 0 to 112, with higher scores indicating greater levels of empathy. Cronbach's alpha ranged from .68 to .80. Participants will complete the IRI at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes over time. Higher scores indicate greater empathy levels.
Baseline, immediately post-intervention, 3-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Gender Role Attitudes (Ambivalent Sexism Inventory - ASI)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
Gender role attitudes will be measured using the Ambivalent Sexism Inventory (ASI), which assesses two factors: hostile and benevolent sexism. We will use the brief version composed of 12 items (6 items in each factor) with Cronbach's alphas of .75 and .81. Higher scores indicate greater sexist attitudes. Participants will complete the ASI at baseline, post-intervention, and 3-month follow-up to evaluate changes in gender-related beliefs.
Baseline, immediately post-intervention, 3-month follow-up
Change in Communication Patterns (Communication Patterns Questionnaire - CPQ)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
Communication patterns in close relationships will be assessed using the Spanish version of the Communication Patterns Questionnaire (CPQ). The CPQ is a self-report measure that evaluates three dimensions of communication: mutual constructive communication, communication avoidance or demand/withdrawal, and aggressive communication. Participants will complete the CPQ at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in communication styles over time. The questionnaire consists of 24 items, each rated on a 9-point Likert scale ranging from 1 ("Very unlikely") to 9 ("Very likely"). Higher scores indicate greater use of the corresponding communication strategy. Cronbach alpha in Spain ranged from .62 to .84.
Baseline, immediately post-intervention, 3-month follow-up
Change in Relationship Satisfaction (Dyadic Adjustment Scale - DAS)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
We will use the Spanish brief version of the DAS. It is composed of 13 items answered in a variable Likert scale and those items are grouped under three second order factors and one of first order structure. The scale in its short form presents a cut-off of 44. The higher the score the best adjustment is observed. Cronbach alpha was .83.
Baseline, immediately post-intervention, 3-month follow-up
Change in Couple Flourishing (Couple Flourishing Measure - CFM)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
Couple flourishing will be assessed using the Couple Flourishing Measure (CFM), a unidimensional self-report instrument. The Spanish validated version by Saavedra-Roa et al. will be used in this study. Participants will complete the CFM at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in relationship satisfaction and flourishing over time. The questionnaire consists of 16 items, each rated on a 7-point visual analogue Likert scale ranging from 1 (Distressed relationship), 4 (Satisfied relationship), to 7 (Flourishing relationship). The total score ranges from 16 to 112, with higher scores indicating greater couple flourishing. The instrument demonstrated high internal consistency reliability (α = .94).
Baseline, immediately post-intervention, 3-month follow-up
Change in Acceptance of Modern Myths about Sexual Aggression (AMMSA Scale)
Time Frame: Baseline, immediately post-intervention, 3-month follow-up
Attitudes towards modern myths about sexual aggression will be assessed using the Acceptance of Modern Myths about Sexual Aggression Scale (AMMSA; Gerger et al., 2007). The Spanish adapted and validated version (Megías et al., 2011) will be used in this study. The AMMSA is a self-report measure designed to evaluate subtle beliefs that justify or minimize sexual aggression. Participants will complete the AMMSA at baseline (pre-intervention), immediately post-intervention, and at a three-month follow-up to assess changes in the acceptance of sexual aggression myths over time. The questionnaire consists of 30 items, each rated on a 7-point Likert scale, ranging from 1 ("Totally disagree") to 7 ("Totally agree"). Higher scores indicate greater acceptance of modern myths about sexual aggression. Cronbach alpha in a Spanish sample was .91.
Baseline, immediately post-intervention, 3-month follow-up
Change in Body Ownership Illusion
Time Frame: During VR exposure at two assessment points: (1) Mirror embodiment phase (approximately 5 minutes after VR start) and (2) Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).
Body ownership illusion will be assessed to measure the extent to which participants experience the illusion of embodying their self-avatar and their partner's avatar. This measure evaluates embodiment and agency from a first-person perspective during the VR experience. A validated four-item scale will be administered verbally in two phases: (1) mirror embodiment with the assistant and (2) farewell with the assistant . In the first phase, the assistant will instruct the participant to look into a virtual mirror and ask: "On a scale from 0 to 10, to what extent did you feel that the virtual body in the mirror was your own?" and "When looking down, did you feel that the virtual body was yours?" In the second phase, the assistant will ask: "Did you feel that you owned a different body?" and "Did you feel fear of aggression?" Higher scores indicate a stronger experience of embodiment.
During VR exposure at two assessment points: (1) Mirror embodiment phase (approximately 5 minutes after VR start) and (2) Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).
Change in Physiological Arousal (Pupillometry)
Time Frame: From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.
Physiological arousal will be measured using pupillometry, which records minute fluctuations in the pupil diameter in response to stimuli. Pupil dilation is an indicator of autonomic nervous system activation, and greater pupil dilation is associated with negative emotional processing. The key metric recorded will be pupil diameter ratio (measured in millimeters): the relative change in pupil size in response to VR stimuli. The pupil data will be sampled at a minimum frequency of 60 Hz with a visual angle accuracy of 0.5°. Artifacts such as pupil amplitude outliers (<1 mm or >9 mm), drifts, and blinks will be coded as missing values. A 10 Hz low-pass filter will be applied to smooth the data.
From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.
Change in Visual Attention (Eye-Tracking Data)
Time Frame: From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.
Visual attention will be assessed using eye tracking technology integrated into VR goggles. Eye tracking measures fixation behavior as an indicator of attention allocation toward erotic stimuli, based on sexual objectification theory (Hollett et al., 2022). Two key parameters will be recorded: 1) fixation count (measured in number of fixations): number of available fixations on a specified area of interest (VR model's neckline) and dwell time (measured in milliseconds), and total duration of fixations on the area of interest (neckline). Fixation was defined as a continuous gaze lasting at least 100 ms.
From the start of VR exposure until the completion of the VR session (approximately 15 minutes). Data will be collected in real-time during this period.
Qualitative Insights from Participant Experience
Time Frame: Immediately post-intervention
Participants will complete semi-structured interviews post-intervention to explore their experiences and perceptions of the VR embodiment task. Interviews will be transcribed and analyzed using thematic analysis to identify key themes related to empathy, gender role reflection, and perceived impact of the intervention.
Immediately post-intervention
Changes in affective responses
Time Frame: During VR exposure at one assessment point: Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).
Self-Assessment Manikin (SAM) will be used to assess participants' affective responses during the intervention. This is a non-verbal, pictorial scale that evaluates three dimensions of emotional reaction: Valence (from negative/unpleasant to positive/pleasant), Arousal (from calm to excited), and Dominance (from feeling dominated to feeling in control). Each dimension is rated on a 9-point scale: 1 indicates the lowest intensity (e.g., unpleasant, calm, or dominated), and 9 indicates the highest intensity (e.g., pleasant, excited, or dominant). Higher scores represent more positive emotional valence, higher arousal, and greater sense of control or dominance
During VR exposure at one assessment point: Farewell phase (at the end of VR exposure, approximately 15 minutes after VR start).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 30, 2027

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

March 30, 2027

Study Registration Dates

First Submitted

February 5, 2025

First Submitted That Met QC Criteria

February 17, 2025

First Posted (Actual)

February 21, 2025

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MCIN/AEI/10.13039/501100011033 (Spanish Ministry of Science and Innovation)
  • PID2022-141198OB-I00 (Other Grant/Funding Number: MCIN/AEI/10.13039/501100011033 & FSE+)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared because of privacy and confidentiality concerns, as the study involves sensitive topics related to sexual harassment and gender identity. Given the nature of the intervention and the potential risk of re-identification, all collected data will be stored securely and will only be accessible to the research team in accordance with institutional ethical guidelines and data protection regulations (e.g., GDPR). Aggregated results will be published in peer-reviewed journals, but the raw participant-level data will remain confidential.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe